1. Home
  2. GMED vs ROIV Comparison

GMED vs ROIV Comparison

Compare GMED & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$94.34

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.79

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMED
ROIV
Founded
2003
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
14.1B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
GMED
ROIV
Price
$94.34
$21.79
Analyst Decision
Buy
Strong Buy
Analyst Count
15
8
Target Price
$92.42
$24.31
AVG Volume (30 Days)
1.3M
8.4M
Earning Date
02-19-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
358.86
N/A
EPS
3.08
N/A
Revenue
$2,769,804,000.00
$20,329,000.00
Revenue This Year
$16.86
N/A
Revenue Next Year
$8.05
$741.42
P/E Ratio
$29.40
N/A
Revenue Growth
11.75
N/A
52 Week Low
$51.79
$8.73
52 Week High
$94.93
$23.47

Technical Indicators

Market Signals
Indicator
GMED
ROIV
Relative Strength Index (RSI) 65.50 53.52
Support Level $90.01 $21.15
Resistance Level $94.51 $22.14
Average True Range (ATR) 2.40 0.65
MACD 0.17 -0.13
Stochastic Oscillator 56.33 52.76

Price Performance

Historical Comparison
GMED
ROIV

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: